Cellosaurus cell line 1383D2-B2M-KO #2 (CVCL

Cross-references
Cell line name	1383D2-B2M-KO #2
Accession	CVCL_C1FL
Resource Identification Initiative	To cite this cell line use: 1383D2-B2M-KO #2 (RRID:CVCL_C1FL)
Comments	Population: Asian. Knockout cell: Method=CRISPR/Cas9; HGNC; 914; B2M. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy	Parent: CVCL_UP38 (1383D2)
Sex of cell	Male
Age at sampling	36Y
Category	Induced pluripotent stem cell
Publications	PubMed=30853558; DOI=10.1016/j.stem.2019.02.005 Xu H.-G., Wang B., Ono M., Kagita A., Fujii K., Sasakawa N., Ueda T., Gee P., Nishikawa M., Nomura M., Kitaoka F., Takahashi T., Okita K., Yoshida Y., Kaneko S., Hotta A. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24:566-578.e7(2019) Patent=US20200407693 Hotta A., Xu H.-G., Kaneko S., Wang B. Method for producing low-antigenic cell. Patent number US20200407693, 31-Dec-2020
Encyclopedic resources	Wikidata; Q114310348
Entry history
Entry creation	22-Sep-2022
Last entry update	29-Jun-2023
Version number	4